Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Scholar Rock Holding Corp (NQ: SRRK )

13.46 -1.09 (-7.49%)
Streaming Delayed Price Updated: 1:26 PM EDT, May 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Scholar Rock Holding Corp

< Previous 1 2 3 4 5 6 7 Next >
Scholar Rock Receives Fast Track Designation from the U.S. FDA for Apitegromab for the Treatment of Patients with Spinal Muscular Atrophy
From Scholar Rock
Via Business Wire
Scholar Rock to Present Trials in Progress Poster for SRK-181 DRAGON Phase 1 Clinical Trial at the American Society of Clinical Oncology Annual Meeting
From Scholar Rock
Via Business Wire
Scholar Rock Reports First Quarter 2021 Financial Results and Highlights Business Progress
From Scholar Rock
Via Business Wire
Scholar Rock Announces Publication of Phase 1 Clinical Trial Data Evaluating Apitegromab in Healthy Volunteers in the Journal Advances in Therapy
From Scholar Rock
Via Business Wire
The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 26) 10x Genomics, Inc. (NASDAQ... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Scholar Rock Announces Issuance of U.S. Patent Broadly Relevant to Inhibitors of Myostatin Activation
From Scholar Rock, Inc.
Via Business Wire
Scholar Rock Stock Shows Market Leadership With Healthy Jump To 83 RS Rating
When looking for the best stocks to buy and watch, focus on those with rising relative price strength. Scholar Rock stock fits that bill. 
Via Investor's Business Daily
Scholar Rock Presents Biomarker Strategy to Support the SRK-181 DRAGON Phase 1 Proof-of-Concept Trial at the American Association for Cancer Research Annual Meeting
From Scholar Rock, Inc.
Via Business Wire
51 Biggest Movers From Yesterday
Gainers UTime Limited (NASDAQ: UTME) shares jumped 875% to close at $39.00 on Tuesday after the company priced its IPO at $4 per share. Romeo Power, Inc. (NYSE: RMO) climbed 59.6... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Mid-Afternoon Market Update: Dow Falls 50 Points; Scienjoy Shares Spike Higher
Toward the end of trading Tuesday, the Dow traded down 0.15% to 33,475 while the NASDAQ rose 0.12% to 13,721.59. The S&P also rose, gaining 0.03% to 4,078.98. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Second Sight Medical (NASDAQ:EYES) stock increased by 33.37% to $9.87 during Tuesday's regular session. As of 12:32 EST, this security is trading at a volume... 
Via Benzinga
Mid-Day Market Update: Crude Oil Rises Over 2%; Scholar Rock Shares Plunge
Midway through trading Tuesday, the Dow traded down 0.05% to 33,510.72 while the NASDAQ rose 0.48% to 13,771.47. The S&P also rose, gaining 0.20% to 4,086.01. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why Scholar Rock Shares Dropped Despite Positive Apitegromab Data In Spinal Muscular Atrophy
Scholar Rock (NASDAQ: SRRK) shares dropped despite the company reporting positive 12-month data on spinal muscular atrophy (SMA) candidate apitegromab. The 12... 
Via Benzinga
33 Stocks Moving In Tuesday's Mid-Day Session
Gainers Scienjoy Holding Corporation (NASDAQ: SJ) shares jumped 67.4% to $16.04 after the company announced a strategic alliance with Snipp to launch a new loyalty and rewards... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.